Preliminary Results from a Phase II Study of the Combination of Azacitidine and Pembrolizumab in Patients with Higher-Risk Myelodysplastic Syndrome
暂无分享,去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | N. Jain | K. Naqvi | K. Chien | Kimberly B. Sheppard